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Abstract
Feeling of presence (FOP) refers to the vivid sensation of a person’s presence near oneself and is common inDementia with Lewy
Bodies (DLB). Based on previous observations on epileptic subjects, we hypothesized that DLB subjects with FOP would
harbour 18F-fluorodeoxyglucose PET hypometabolism in left parietal areas. 25 subjects (mean age 71.9 ± 6.7, disease duration
at scan 1.7 ± 1.5 years) were included in the study, of whom nine (36%) experienced FOP. No significant between-group
difference was observed regarding dopamine transporters striatal uptake (p = 0.64), daily dopaminergic treatment dosage (p =
0.88) and visual hallucinations (p = 0.83). Statistical parametric mapping showed that subjects with FOP had a significantly
reduced glucose metabolism in several left frontoparietal areas (p < 0.001), including superior parietal lobule and precuneus.
Interregional correlation analysis of these areas showed specific connectivity with right insula and putamen in the FOP subgroup
and right orbitofrontal and superior frontal in subjects without FOP. This provides further evidence about the role of a left
frontoparietal network and suggest a possible contribution of impaired orbitofrontal reality filtering associated with FOP.
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Introduction
Dementia with Lewy bodies (DLB) is the second most com-
mon degenerative dementia after Alzheimer’s disease (AD),
accounting for 15% of cases (Vann Jones and O'Brien 2014;
Zaccai et al. 2005). It is characterized by a progressive cogni-
tive decline interfering with activities of daily living in
association with core clinical features of parkinsonism, visual
hallucinations (VH), cognitive fluctuations and REM sleep
behavior disorder. The recently revised diagnostic criteria
(McKeith et al. 2017) have integrated decreased posterior me-
tabolism on 18F-FDG-PET and considered as an indicative
biomarker the presence of reduced dopaminergic uptake in
the basal ganglia on 123I-FP-CIT single photon emission com-
puted tomography (SPECT) imaging in order to increase di-
agnostic accuracy and provide specific management consider-
ations (Boot 2015; O'Brien et al. 2014; Thomas et al. 2017).
Although there is no available specific marker of Lewy body
pathology (Bauckneht et al. 2017), dopaminergic SPECT pro-
vides excellent sensitivity and specificity (resp. 78 and 90%)
to discriminate neuropathology-confirmed cases of DLB
(McKeith et al. 2007) from other dementias like AD.
Adding semiquantitative assessment to the standard visual
analysis allows even greater accuracy (Nicastro et al. 2017).
Feeling of presence (FOP) refers to the vivid sensation that
somebody is present near oneself in the absence of any sen-
sory clue. It has been described in various conditions such as
schizophrenia (Koehler and Sauer 1984), epilepsy (Arzy et al.
2006; Blanke et al. 2003), Parkinson’s disease (Fenelon et al.
2000), and DLB (Nagahama et al. 2010). FOP is the most
frequently encountered psychotic symptom in patients with
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Parkinson’s disease (34–44%) (Fenelon et al. 2011; Williams
et al. 2008). It is usually short-lived (a few seconds), rarely
distressing, and although patients usually have a preserved
insight about the Bfictitious^ nature of this feeling, they have
a tendency to check for a real presence. FOP usually occurs
behind or beside the subject, without any side predominance
(Fenelon et al. 2011). Independent predictors include concom-
itant VH and possibly higher daily levodopa dosage. Besides,
Nagahama et al. (2010) have described significant 99mTc
HMPAOSPECT hypoperfusion of bilateral angular gyrus, left
fourth occipital gyrus and right supramarginal gyrus in DLB
patients experiencing cluster symptoms of VH and FOP. Right
occipitotemporal hypometabolism has been described in sub-
jects with visual hallucinations (Perneczky et al. 2008).
With the present study, we aimed at evaluating specific FDG-
PET hypometabolism in a retrospective cohort of subjects with
probable DLB, based on statistical parametric mapping (SPM)
analysis. Considering observations on epileptic patients
experiencing FOP during electrostimulation or seizure (Arzy
et al. 2006; Blanke et al. 2003; Picard 2010; Zijlmans et al.
2009), our hypothesis was that DLB subjects with FOP (FOP+
)would have a reducedmetabolism in left temporoparietal cortex
in comparison to those without FOP (FOP-). In addition, we
aimed at determining whether FOP+ have a higher levodopa
equivalent daily dose (LEDD) and a reduced presynaptic dopa-
mine SPECT uptake in comparison to FOP-.
Method
Participants
The present study has been conducted in compliance with the
declaration of Helsinki and our local Ethics Committee has ap-
proved its protocol (NAC 12-026R). We collected clinical data
(gender, age and disease duration at scan, clinical diagnosis) from
all subjects for which both 123I-FP-CIT SPECT and 18F-FDG
PET were available for analysis, provided they were performed
at amaximum of 2months apart.We considered all subjects who
underwent scans from October 2003 to October 2016 within
Geneva University Hospitals with the same acquisition and im-
age processing protocols. We then included all patients
harbouring a clinical diagnosis of probable DLB according to
the most recent consensus criteria of McKeith et al. (2017).
Although FDG PET is not necessary for the diagnosis of DLB,
we have been able to collect this imaging data for our cohort
either because the subjects were first evaluated for suspected AD
(visuospatial impairment with no or mild parkinsonism), or be-
cause 123I-FP-CIT SPECT only showed moderate presynaptic
DAT impairment, thus requiring another imaging evaluation to
confirm a posterior hypometabolism evoking DLB.
Based on the information in the medical file, we searched
for FOP description (presence, side predominance), as well as
clinical features possibly associatedwith FOP, such as severity
of parkinsonism based on Movement Disorders Society
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS
III) (Goetz et al. 2008), cognitive decline (Mini-Mental State
Evaluation, MMSE, (Folstein et al. 1975)) and levodopa
equivalent daily dose (LEDD, (Tomlinson et al. 2010)).
PET and SPECT imaging acquisition
and reconstruction
FDG-PET
Subjects received 250 MBq of 18F-FDG in slow IV injection
under standardized conditions (supine position, low ambient
noise, dimly- lit room, eyes open). Usual medication schemes
were continued before and on the day of scan. PET/CT data
acquisition was performed on a Biograph tomograph
(Siemens Healthcare, Erlangen, Germany) using manufac-
turer’s recommendations and according to the European
Association of Nuclear Medicine Neuroimaging Committee
(Varrone et al. 2009). PET acquisition started approx. 30 min
after the ligand injection. CT study was used for attenuation
and scatter correction, then followed by PET emission study
(20 min). We used an ordered-subset-expectation-
maximisation (OSEM) algorithm for image reconstruction.
FP-CIT SPECT
123I-FP-CIT SPECT was performed according to the manu-
facturer’s instructions. Patients received 185 MBq of 123I-FP-
CIT (ioflupane, DaTSCAN®, GE Healthcare) in slow IV in-
jection and Lugol solution (or sodium perchlorate) for thyroid
blockade. SPECT data acquisition started 4 h after ioflupane
injection. Acquisition was performed on the same triple-head
gamma camera (GCA-9300A/UI Toshiba Medical Systems
AG, Oetwil am See, Switzerland) equipped with fan beam
low-energy high-resolution collimators. Details of the acqui-
sition and reconstruction are available in (Nicastro et al.
2016b).
SPM for PET FDG-PET brain images were pre-processed using
Statistical Parametric Mapping (SPM12, Wellcome Trust
Centre for Neuroimaging, London, UK, http://www.fil.ion.
ucl.ac.uk/spm/software/SPM12/), running in Matlab R2017a
Version 9.2.0 (MathWorks Inc., Sherborn, MA). We
performed approximate manual image re-orientation and po-
sitioning to a T1 MRI template available in SPM toolbox.
Images were spatially normalized and written in the default
SPM12 bounding box with an isotropic voxel size of 2 × 2 ×
2 mm. Visual inspection of normalized images allowed to
ensure registration quality and convergence of the procedure.
Image smoothing was performed with an isotropic 3D
Gaussian kernel of 8 mm full width at half-minimum
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(FWHM). We performed a two-sample t-test (subjects with
and without FOP) with Analysis of Covariance (ANCOVA)
design, corrected for age and gender. Intensity normalization
was performed using the individual pontine metabolism as it
has been shown not to be affected in subjects with dementia
(Borghammer et al. 2008; Minoshima et al. 1995). T-maps
contrasts were obtained by comparing DLB subjects with
(−1) and without FOP (+1), with an uncorrected threshold at
0.001. To report corresponding brain areas, we used coordi-
nates from Montreal Neurological Institute (MNI) (Mazziotta
et al. 1995) and Wake Forest University (WFU) Pickatlas
Software Version 3.0.5 toolbox running on SPM12
(Maldjian et al. 2003). In addition, we performed for both
subgroups interregional correlation analysis (IRCA) (Lee
et al. 2008) of extracted mean regional volumes of interest
counts (normalized with respect to pontine mean counts) as
covariate to find regions presenting significant voxel-wise
positive and negative correlations with the ones showing sig-
nificant hypometabolism in FOP+ group (uncorrected p < 0.
001, extent threshold k = 20 voxels). This method has been
used in subjects with AD (Morbelli et al. 2012). As left
temporoparietal junction (TPJ) has been shown to induce
FOP in epileptic subjects, we also assessed IRCA of TPJ by
creating a spherical 10 mm-mask with MNI coordinates as
found in the publication of Sowden et al. (Sowden and
Catmur 2015). For both subgroups, IRCA of adjacent regions
to TPJ was also studied (left angular, supramarginal, and su-
perior temporal gyri).
Reference limits for SPECT We collected standard 0-to-3
(Benamer et al. 2000) visual staging in the initial nuclear med-
icine report available in the patients’medical file. Site-specific
semiquantitative reference values have been established in a
previous publication and formulae to determine striatal,
caudate nucleus and putaminal uptake limits (Nicastro et al.
2016a) have been applied to assess specific uptake of included
subjects, expressed in %.
Statistical analysis
We used Stata Version 14.2 software (College Station, TX) for
statistical analysis. Continuous variables were tested for nor-
mality with the Shapiro-Wilk test. We used t-test for continu-
ous variables with a normal distribution, Wilcoxon Rank Sum
(Mann-Whitney U Test) for non-parametric variables and Chi-
Square test for discrete variables accordingly. Statistical sig-
nificance was considered if p value <0.05. We reported values
as mean ± standard deviation (SD) (range).
Results
Patient demographics and clinical caracteristics
We identified 25 subjects fulfilling McKeith diagnostic
criteria of probable DLB for which both 18F-FDG PET and
123I-FP-CIT SPECT were performed according to the afore-
mentioned criteria. Baseline characteristics of included sub-
jects are available in Table 1. For the whole group, age was
71.9 ± 6.7 years (range 58–86), with 32.0% female (8/25) and
disease duration 1.7 ± 1.5 years (0.25–7). Among these, we
identified nine FOP+ and 16 FOP-. There was no statistical
difference between both subgroups regarding age, disease du-
ration, and male/female ratio. In addition, MMSE score, pres-
ence of visual hallucinations and 123I-FP-CIT SPECT visual
and semiquantitative assessments did not differ between
FOP+ and FOP- subjects. Similarly, there was no statistical
Table 1 Baseline characteristics
All DLB FOP No FOP Pval
# 25 9 16
Age (years) 71.9 ± 6.7 (58–86) 71.2 ± 6.9 (58–78) 72.3 ± 6.8 (61–86) 0.70#
Female Gender % 32.0% (8/25) 22.2% (2/9) 37.5% (6/16) 0.43&
Disease duration (years) 1.7 ± 1.5 (0.25–7) 2.1 ± 2.2 (0.25–7) 1.5 ± 1.0 (0.25–3) 0.62*
MMSE 21.6 ± 4.8 (11–26) 22.8 ± 5.6 (13–26) 21.1 ± 4.5 (11–26) 0.19*
MDS-UPDRS III 13.1 ± 14.0 (0–52) 11.7 ± 14.1 (0–44) 13.9 ± 14.4 (0–52) 0.68*
LEDD (mg) 112 ± 233 (0–800) 109.8 ± 266.2 (0–800) 113.3 ± 221.6 (0–750) 0.88*
Visual Hallucinations 64% (16/25) 66.7% (6/9) 62.5% (10/16) 0.83&
Dopamine SPECT visual stage 1.9 ± 0.9 (0–3) 2.0 ± 0.7 (0–3) 1.9 ± 1.1 (0–3) 0.82&
Mean striatal dopamine SPECT uptake 1.79 ± 0.64 (0.77–2.91) 1.71 ± 0.55 (0.88–2.62) 1.84 ± 0.70 (0.77–2.91) 0.64#
% mean striatal dopamine SPECT uptake
(according to reference limits)
75.1 ± 25.7 (33.5–117) 71.2 ± 21.4 (37.5–97.8) 77.4 ± 28.2 (33.5–117) 0.57#
Baseline characteristics of DLB subjects included in the study. Values are mean ± SD (range). Statistical tests (FOP+ vs FOP- subgroups): * Wilcoxon
Rank Sum (Mann-Whitney U), # Student T, & Chi-Squared
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Regarding the FOP subgroup, 6/9 (66.7%) subjects felt the
presence beside them and 3/9 (33.3%) behind them. When
FOP was felt beside the patient, it was perceived on right
(2/6), left (1/6) or both sides (3/6).
FOP+ showed signi f icant ly more pronounced
hypometabolism compared with FOP- in left parietal (superior
parietal lobule and precuneus) as well as frontal areas (middle,
superior and precentral gyri) (uncorrected p < 0.001) (Table 2;
Fig. 1). No significant clusters survived false discovery rate
(FDR) or family-wise error (FWE) p < 0.05 correction.
Connectivity analysis
In both subgroups, IRCA of the seed regions included large
clusters with a significant positive correlation, encompassing
left temporoparietal junction, left superior and mid frontal
gyri, as well as the right 8th cerebellar hemisphere. Specific
IRCAwas found for the FOP+ group in right putamen, insula
and lingual gyrus (Table 3). On the other hand, FOP- subjects
specifically showed right orbitofrontal and superior frontal
connectivity (Fig. 2).
The IRCA did not identify significant negative correlations
with these regions.
Table 2 Hypometabolic clusters associated with FOP
Cluster Region Voxels x y z Z-
score
1 Middle frontal gyrus, left 79 −34 -10 62 4.14
2 Superior parietal lobule, left 30 −18 -60 66 3.75
3 Precuneus, left 112 −40 -72 42 3.71
4 Superior frontal gyrus, left 98 −4 58 38 3.68
5 Precentral gyrus, left 34 −16 -20 74 3.54
Brain regions showing significant hypometabolism in relation to FOP. X
Y Z = stereotactic coordinates in MNI space; Z score = SPM(Z) score
Fig. 1 Slice overlay of the major
hypometabolic clusters in the
FOP+ group (uncorrected p <
0.001). The SPM(Z) result image
has been overlaid on a template
T1 MRI. Numbers indicate the Z
coordinates according to MNI.
L = left. Scale shows T-Score
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Discussion
FOP is frequently encountered in subjects with DLB, as al-
ready shown by other authors (Nagahama et al. 2010). In the
present study, we found that 36% (9/25) of retrospectively
evaluated probable DLB patients experienced such symp-
toms. We observed that FOP was perceived behind (33.3%)
of beside (66.7%) the subject, without any side predominance
in the latter case. Interestingly, subgroups with and without
FOP have similar age, disease duration, as well as cognitive
(MMSE) and motor impairment (MDS-UPDRS III). At vari-
ance with another study including PD subjects (Fenelon et al.
2011), VHwas not a predictor of FOP in our DLB population.
One hypothesis could be that in the case of PD subjects, both
VH and FOP should be considered as symptoms of severe and
widespread cortical damage (in the study of Fenelon, disease
Table 3 Interregional correlation analysis of hypometabolic clusters and putative regions implicated in FOP
FOP+ subjects (n = 9) FOP- subjects (n = 16)






R Cerebellum (8th hemisphere)
L middle Frontal (autocorr.)
L middle Temporal
R Supramarginal and middle Temporal
R Cerebellum (8th hem.)
L Superior Frontal L superior Frontal (autocorr.)
L Superior Temporal
R and L Insula
R and L Precuneus
R lingual
L and R Superior and Middle Frontal (autocorr.)
L and R Inferior Temporal
L and R angular and supramarginal
R Cerebellum (8th hem.)




R and L Superior Parietal
R Putamen
L and R Precentral (auto)













L and R Precuneus and superior Parietal (autocorr.)
L Superior Parietal L Superior Frontal
R middle Temporal pole
R Superior Parietal
L inferior and superior Parietal (autocorr.)
R superior Frontal
L superior Parietal and Precuneus (autocorr.)




Middle Temporal, angular and inferior
Parietal (autocorr.)
L supramarginal L Precentral
R Insula
L angular, supramarginal, superior and middle Temporal (autocorr.)
R Precuneus
R Cerebellum (8th hem.)
L Inferior and superior Frontal
R middle and superior Orbitofrontal
R middle Temporal
R Cerebellum (8th hem.)
L Superior Temporal L Superior and middle Temporal (autocorr.)
R Insula
R Cerebellum (8th hem.)
L and R middle and superior Temporal (autocorr.)
R Cerebellum (8th hem.)
LTemporoparietal junction L Superior Frontal
L Precentral
R Insula
L angular, supramarginal and Superior Temporal (autocorr.)
R Precuneus
R Cerebellum (8th hem.)
L and R middle Frontal
L middle Temporal, angular and
supramarginal (autocorr.)
R supramarginal
Interregional Correlation Analysis (IRCA) of the five hypometabolic FDG PET clusters in subgroup with FOP, as well as putative areas implicated in
FOP (left temporoparietal junction and adjacent regions) used as seeds. Positive correlation, uncorrected p < 0.001, extent threshold >20 voxels. L = left,
R = right
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duration of PD patients with FOP was 11 years). In our case,
VH are much more prevalent (64% of the whole DLB group),
as it is a core clinical feature of DLB. Besides, we observed
similar LEDD and UPDRS score in FOP+ and FOP-. At var-
iance with the study of Fenelon, our DLB subjects had a much
lower L-Dopa daily intake (mean 112 vs 959 mg/day), so this
could be explained either by a smaller effect size or by differ-
ent mechanisms eliciting FOP in DLB and PD patients.
SPM analysis of FDG-PET showed significantly reduced
metabolism in left frontal and parietal areas in the FOP+ sub-
group, when compared to FOP- DLB subjects. More specifi-
cally, FOP was associated with a more pronounced
hypometabolism in precuneus, superior parietal lobule, as
well as superior, middle frontal and precentral gyri, all in the
left hemisphere (uncorrected p < 0.001). fMRI and PET stud-
ies suggest a role in visuospatial imagery regarding precuneus
(Culham et al. 1998; Malouin et al. 2003). The superior pari-
etal lobule is involved in spatial orientation (Galletti and
Fattori 2017) and has been implicated in distinction of body
parts in self and non-self (Felician and Romaiguere 2008).
IRCA in the FOP+ group showed that these five clusters
were functionally connected to various regions including right
putamen, insula and lingual gyrus, whereas FOP- subjects
showed a different connectivity including right superior fron-
tal gyrus.
To the best of our knowledge, the neural correlate of FOP
in DLB subjects was only studied by Nagahama et al. (2010)
using 99mTc HMPAO, with significant hypoperfusion in bilat-
eral angular gyri, left fourth occipital and right supramarginal
gyrus. However, it must be emphasized that analyses were
performed for a symptom cluster associating VH and FOP,
the former accounting (as suggested by the authors) for the
major effect as 92% of the group had VH, whereas only 39%
presented FOP. There is substantial evidence that VH in pa-
tients with PD and DLB are correlated with posterior
hypometabolism on FDG-PET, especially in bilateral
precuneus and lingual gyrus (Boecker et al. 2007; Gasca-
Salas et al. 2016; Perneczky et al. 2008). In addition, occipital
and fusiform gyrus SPECT hypoperfusion has been observed
(Heitz et al. 2015; Oishi et al. 2005). However, it is unclear
whether FOP phenomenon shares similar neural basis with
VH.
Cortical electrostimulation in subjects suffering from epi-
lepsy can be enlightening to understand the specific regions
Fig. 2 Slice overlay for FOP+ (part A) and FOP- (part B) subjects show-
ing interregional correlation analysis (IRCA) with left supramarginal gy-
rus (positive correlation, uncorrected p < 0.001, extent threshold >20
voxels). FOP- subjects show a more extended connectivity, including
bilateral superior and orbitofrontal gyri, as well as contralateral
supramarginal gyrus. Numbers indicate Z coordinates according to
MNI. Scale represents T-Score. L = left
1204 Brain Imaging and Behavior (2020) 14:1199–1207
implicated in the pathogenesis of FOP. In fact, electrocortical
stimulation of the left parietotemporal (Arzy et al. 2006) and
parietotemporooccipital junction (Zijlmans et al. 2009) has
been described to elicit FOP similar to those experienced by
PD and DLB subjects, i.e. the intense and short-lived sensa-
tion of a presence next to the patient. Notably, our findings are
very close, as the main cluster of hypometabolism in DLB
with FOP is located in the left parietal lobe (superior parietal
lobule and precuneus), which is near the parietotemporal junc-
tion. In addition, IRCA of left TPJ and adjacent areas (left
supramarginal, angular and superior temporal gyri) in our
FOP+ subgroup shows a connectivity pattern similar to that
of hypometabolic regions in FOP+, i.e. a network
encompassing left superior and mid Frontal gyrus and right
cerebellum. Besides, additional connectivity was observed for
FOP- subjects in right superior and orbitofrontal gyri, which
are implicated in reality filtering (Schnider 2013). This finding
can be considered as a possible explanation for the occurrence
of FOP in selected DLB subjects.
However, further speculations cannot be inferred from our
study, as it is based on a functional PET analysis aimed at
evaluating the baseline metabolism of DLB subjects with or
without FOP and not to assess the critical region which is
stimulated during the actual experience of FOP.
FOP+ and FOP- subjects show similar striatal uptake on
dopamine SPECT with both visual staging and semiquantita-
tive assessment. In our opinion, this finding is not surprising,
as FOP presumably represents a symptom of cortical alter-
ation that has been described in patients with epilepsy and
schizophrenia, the mechanisms of which are not related to
an impairment of dopaminergic pathways.
Several limitations must be addressed regarding the present
work. First, as it is the case for the majority of studies on this
topic, diagnosis of DLB was not based on the gold standard
neuropathological confirmation, but on clinical and PET/
SPECT evaluation. We nonetheless used the most recent di-
agnostic criteria of probable DLB in association with a de-
creased presynaptic dopaminergic uptake on 123I-FP-CIT
SPECT and a t yp i c a l po s t e r i o r 1 8F -FDG PET
hypometabolism. Second, sample size is quite small but we
were still able to demonstrate a significantly more pronounced
hypometabolism in various clusters for DLB subjects with
FOP. With regard to FDG-PET cluster determination, the ex-
ploratory nature of the study and the relatively reduced sample
allowed us to use a liberal uncorrected p < 0.001 threshold and
we were not able to replicate these findings with a more strin-
gent FDR or FWE p < 0.05 correction. Finally, we cannot
exclude that due to the retrospective design of our study, we
may have missed additional subjects having experienced FOP
but whose information was not notified in the medical file.
DLB subjects experiencing FOP have a reduced FDG-PET
metabolism in left frontoparietal areas and a different connec-
tivity map that FOP- subjects. The former present a network
including the right putamen and insula, whereas the latter
show more extended connections with contralateral homolo-
gous areas, as well as with right superior and orbitofrontal
areas, known to be associated with reality filtering. On the
other hand, presynaptic dopamine SPECT imaging striatal
uptake impairment as well as dopaminergic treatment do not
seem to be correlated with FOP in our DLB group. These
findings provide major insights into the understanding of psy-
chotic symptoms in subjects with dementia and their function-
al correlation with metabolic imaging, pinpointing to a
disrupted left frontoparietal network underpinning FOP.
Funding This research did not receive any specific grant. VGwas funded
by a grant from the Swiss National Science Foundation (SNF 320030_
169876) and from the Velux Foundation (project 1123).
Compliance with ethical standards
Conflicts of interest The authors report no conflict of interest.
Ethical approval The present study was performed in agreement with
the Declaration of Helsinki and its further amendments. Approval was
obtained from the Canton of Geneva Ethics Committee (protocol NAC
12-026R).
Informed consent As a retrospective analysis of imaging data, the
Geneva Ethics Committee waived the need for informed written consent.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
Publisher’s Note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
References
Arzy, S., Seeck, M., Ortigue, S., Spinelli, L., & Blanke, O. (2006).
Induction of an illusory shadow person. Nature, 443(7109), 287.
Bauckneht, M., Arnaldi, D., Nobili, F., Aarsland, D., & Morbelli, S.
(2017). New tracers and new perspectives for molecular imaging
in Lewy body diseases. Current Medicinal Chemistry.
Benamer, T. S., Patterson, J., Grosset, D. G., Booij, J., de Bruin, K., van
Royen, E., Speelman, J. D., Horstink, M. H., Sips, H. J., Dierckx, R.
A., Versijpt, J., Decoo, D., Van Der Linden, C., Hadley, D.M., Doder,
M., Lees, A. J., Costa, D. C., Gacinovic, S., Oertel, W. H., Pogarell,
O., Hoeffken, H., Joseph, K., Tatsch, K., Schwarz, J., & Ries, V.
(2000). Accurate differentiation of parkinsonism and essential tremor
using visual assessment of [123I]-FP-CIT SPECT imaging: The
[123I]-FP-CIT study group.Movement Disorders, 15(3), 503–510.
Blanke, O., Ortigue, S., Coeytaux, A., Martory, M. D., & Landis, T.
(2003). Hearing of a presence. Neurocase, 9(4), 329–339.
Boecker, H., Ceballos-Baumann, A. O., Volk, D., Conrad, B., Forstl, H.,
& Haussermann, P. (2007). Metabolic alterations in patients with
Parkinson disease and visual hallucinations. Archives of
Neurology, 64(7), 984–988.
1205Brain Imaging and Behavior (2020) 14:1199–1207
Boot, B. P. (2015). Comprehensive treatment of dementia with Lewy
bodies. Alzheimer's Research & Therapy, 7(1), 45.
Borghammer, P., Jonsdottir, K. Y., Cumming, P., Ostergaard, K., Vang,
K., Ashkanian, M., Vafaee, M., Iversen, P., & Gjedde, A. (2008).
Normalization in PET group comparison studies–the importance of
a valid reference region. Neuroimage, 40(2), 529–540.
Culham, J. C., Brandt, S. A., Cavanagh, P., Kanwisher, N. G., Dale, A.
M., & Tootell, R. B. (1998). Cortical fMRI activation produced by
attentive tracking of moving targets. Journal of Neurophysiology,
80(5), 2657–2670.
Felician, O., & Romaiguere, P. (2008). Your body and mine: A neuro-
psychological perspective. Neurophysiologie Clinique, 38(3), 183–
187.
Fenelon, G., Mahieux, F., Huon, R., & Ziegler, M. (2000). Hallucinations
in Parkinson's disease: Prevalence, phenomenology and risk factors.
Brain, 123(Pt 4), 733–745.
Fenelon, G., Soulas, T., Cleret de Langavant, L., Trinkler, I., & Bachoud-
Levi, A. C. (2011). Feeling of presence in Parkinson's disease.
Journal of Neurology, Neurosurgery, and Psychiatry, 82(11),
1219–1224.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental
state". A practical method for grading the cognitive state of patients
for the clinician. Journal of Psychiatric Research, 12(3), 189–198.
Galletti, C., Fattori, P., 2017. The dorsal visual stream revisited: Stable
circuits or dynamic pathways? Cortex.
Gasca-Salas, C., Clavero, P., Garcia-Garcia, D., Obeso, J. A., &
Rodriguez-Oroz, M. C. (2016). Significance of visual hallucinations
and cerebral hypometabolism in the risk of dementia in Parkinson's
disease patients with mild cognitive impairment. Human Brain
Mapping, 37(3), 968–977.
Goetz, C.G., Tilley, B.C., Shaftman, S.R., Stebbins, G.T., Fahn, S.,
Martinez-Martin, P., Poewe, W., Sampaio, C., Stern, M.B., Dodel,
R., Dubois, B., Holloway, R., Jankovic, J., Kulisevsky, J., Lang,
A.E., Lees, A., Leurgans, S., LeWitt, P.A., Nyenhuis, D., Olanow,
C.W., Rascol, O., Schrag, A., Teresi, J.A., van Hilten, J.J., LaPelle,
N., Movement Disorder Society, U.R.T.F., 2008. Movement
Disorder Society-sponsored revision of the unified Parkinson's dis-
ease rating scale (MDS-UPDRS): Scale presentation and clinimetric
testing results. Movement Disorders 23(15), 2129–2170.
Heitz, C., Noblet, V., Cretin, B., Philippi, N., Kremer, L., Stackfleth, M.,
Hubele, F., Armspach, J. P., Namer, I., & Blanc, F. (2015). Neural
correlates of visual hallucinations in dementia with Lewy bodies.
Alzheimer's Research & Therapy, 7(1), 6.
Koehler, K., & Sauer, H. (1984). Jaspers' sense of presence in the light of
Huber's basic symptoms and DSM-III. Comprehensive Psychiatry,
25(2), 183–191.
Lee, D. S., Kang, H., Kim, H., Park, H., Oh, J. S., Lee, J. S., & Lee, M. C.
(2008). Metabolic connectivity by interregional correlation analysis
using statistical parametric mapping (SPM) and FDG brain PET;
methodological development and patterns of metabolic connectivity
in adults. European Journal of Nuclear Medicine and Molecular
Imaging, 35(9), 1681–1691.
Maldjian, J. A., Laurienti, P. J., Kraft, R. A., & Burdette, J. H. (2003). An
automated method for neuroanatomic and cytoarchitectonic atlas-
based interrogation of fMRI data sets. Neuroimage, 19(3), 1233–
1239.
Malouin, F., Richards, C. L., Jackson, P. L., Dumas, F., & Doyon, J.
(2003). Brain activations during motor imagery of locomotor-
related tasks: A PET study. Human Brain Mapping, 19(1), 47–62.
Mazziotta, J. C., Toga, A. W., Evans, A., Fox, P., & Lancaster, J. (1995).
A probabilistic atlas of the human brain: Theory and rationale for its
development. The international consortium for brain mapping
(ICBM). Neuroimage, 2(2), 89–101.
McKeith, I., O'Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J.,
Padovani, A., Giubbini, R., Bonuccelli, U., Volterrani, D., Holmes,
C., Kemp, P., Tabet, N., Meyer, I., Reininger, C., & Group, D.L.B.S.
(2007). Sensitivity and specificity of dopamine transporter imaging
with 123I-FP-CIT SPECT in dementia with Lewy bodies: A phase
III, multicentre study. Lancet Neurology, 6(4), 305–313.
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J. P.,
Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G.,
Bayston, A., Beach, T. G., Blanc, F., Bohnen, N., Bonanni, L., Bras,
J., Brundin, P., Burn, D., Chen-Plotkin, A., Duda, J. E., El-Agnaf,
O., Feldman, H., Ferman, T. J., Ffytche, D., Fujishiro, H., Galasko,
D., Goldman, J. G., Gomperts, S. N., Graff-Radford, N. R., Honig,
L. S., Iranzo, A., Kantarci, K., Kaufer, D., Kukull,W., Lee, V. M. Y.,
Leverenz, J. B., Lewis, S., Lippa, C., Lunde, A., Masellis, M.,
Masliah, E., McLean, P., Mollenhauer, B., Montine, T. J., Moreno,
E., Mori, E., Murray, M., O'Brien, J. T., Orimo, S., Postuma, R. B.,
Ramaswamy, S., Ross, O. A., Salmon, D. P., Singleton, A., Taylor,
A., Thomas, A., Tiraboschi, P., Toledo, J. B., Trojanowski, J. Q.,
Tsuang, D., Walker, Z., Yamada, M., & Kosaka, K. (2017).
Diagnosis and management of dementia with Lewy bodies: Fourth
consensus report of the DLB consortium.Neurology, 89(1), 88–100.
Minoshima, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1995).
Preserved pontine glucose metabolism in Alzheimer disease: A ref-
erence region for functional brain image (PET) analysis. Journal of
Computer Assisted Tomography, 19(4), 541–547.
Morbelli, S., Drzezga, A., Perneczky, R., Frisoni, G. B., Caroli, A., van
Berckel, B. N., Ossenkoppele, R., Guedj, E., Didic, M., Brugnolo,
A., Sambuceti, G., Pagani, M., Salmon, E., & Nobili, F. (2012).
Resting metabolic connectivity in prodromal Alzheimer's disease.
A European Alzheimer disease consortium (EADC) project.
Neurobiology of Aging, 33(11), 2533–2550.
Nagahama, Y., Okina, T., Suzuki, N., & Matsuda, M. (2010). Neural
correlates of psychotic symptoms in dementia with Lewy bodies.
Brain, 133(Pt 2), 557–567.
Nicastro, N., Garibotto, V., Badoud, S., Burkhard, P.R., 2016a. Scan
without evidence of dopaminergic deficit: A 10-year retrospective
study. Parkinsonism Relat Disord 31, 53–58.
Nicastro, N., Garibotto, V., Poncet, A., Badoud, S., & Burkhard, P. R.
(2016b). Establishing on-site reference values for (123)I-FP-CIT
SPECT (DaTSCAN(R)) using a cohort of individuals with non-
degenerative conditions. Molecular Imaging and Biology, 18(2),
302–312.
Nicastro, N., Garibotto, V., Allali, G., Assal, F., & Burkhard, P. R. (2017).
Added value of combined semi-quantitative and visual [123I]FP-
CIT SPECT analyses for the diagnosis of dementia with Lewy bod-
ies. Clinical Nuclear Medicine, 42(2), e96–e102.
O'Brien, J. T., Firbank, M. J., Davison, C., Barnett, N., Bamford, C.,
Donaldson, C., Olsen, K., Herholz, K., Williams, D., & Lloyd, J.
(2014). 18F-FDG PET and perfusion SPECT in the diagnosis of
Alzheimer and Lewy body dementias. Journal of Nuclear
Medicine, 55(12), 1959–1965.
Oishi, N., Udaka, F., Kameyama, M., Sawamoto, N., Hashikawa, K., &
Fukuyama, H. (2005). Regional cerebral blood flow in Parkinson
disease with nonpsychotic visual hallucinations. Neurology, 65(11),
1708–1715.
Perneczky, R., Drzezga, A., Boecker, H., Forstl, H., Kurz, A., &
Haussermann, P. (2008). Cerebral metabolic dysfunction in patients
with dementia with Lewy bodies and visual hallucinations.
Dementia and Geriatric Cognitive Disorders, 25(6), 531–538.
Picard, F. (2010). Epileptic feeling of multiple presences in the frontal
space. Cortex, 46(8), 1037–1042.
Schnider, A. (2013). Orbitofrontal reality filtering. Frontiers in
Behavioral Neuroscience, 7, 67.
Sowden, S., & Catmur, C. (2015). The role of the right temporoparietal
junction in the control of imitation. Cerebral Cortex, 25(4), 1107–
1113.
Thomas, A. J., Attems, J., Colloby, S. J., O'Brien, J. T., McKeith, I.,
Walker, R., Lee, L., Burn, D., Lett, D. J., & Walker, Z. (2017).
1206 Brain Imaging and Behavior (2020) 14:1199–1207
Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for
the diagnosis of DLB. Neurology, 88(3), 276–283.
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E.
(2010). Systematic review of levodopa dose equivalency reporting
in Parkinson's disease. Movement Disorders, 25(15), 2649–2653.
Vann Jones, S. A., & O'Brien, J. T. (2014). The prevalence and incidence
of dementia with Lewy bodies: A systematic review of population
and clinical studies. Psychological Medicine, 44(4), 673–683.
Varrone, A., Asenbaum, S., Vander Borght, T., Booij, J., Nobili, F.,
Nagren, K., Darcourt, J., Kapucu, O. L., Tatsch, K., Bartenstein,
P., Van Laere, K., & European Association of Nuclear Medicine
Neuroimaging, C. (2009). EANM procedure guidelines for PET
brain imaging using [18F]FDG, version 2. European Journal of
Nuclear Medicine and Molecular Imaging, 36(12), 2103–2110.
Williams, D. R., Warren, J. D., & Lees, A. J. (2008). Using the presence
of visual hallucinations to differentiate Parkinson's disease from
atypical parkinsonism. Journal of Neurology, Neurosurgery, and
Psychiatry, 79(6), 652–655.
Zaccai, J., McCracken, C., & Brayne, C. (2005). A systematic review of
prevalence and incidence studies of dementia with Lewy bodies.
Age and Ageing, 34(6), 561–566.
Zijlmans, M., van Eijsden, P., Ferrier, C. H., Kho, K. H., van Rijen, P. C.,
& Leijten, F. S. (2009). Illusory shadow person causing paradoxical
gaze deviations during temporal lobe seizures. Journal of
Neurology, Neurosurgery, and Psychiatry, 80(6), 686–688.
1207Brain Imaging and Behavior (2020) 14:1199–1207
